LEM S401
Alternative Names: LEM-S401; siRNA encapsulated in DegradaBALL®Latest Information Update: 28 Aug 2025
At a glance
- Originator Lemonex
- Class Gene therapies; Skin disorder therapies; Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertrophic scars; Keloids
Most Recent Events
- 28 Aug 2025 No recent reports of development identified for phase-I development in Hypertrophic-scars(In volunteers) in South Korea (SC, Injection)
- 28 Aug 2025 No recent reports of development identified for phase-I development in Keloids(In volunteers) in South Korea (SC, Injection)
- 03 Feb 2023 Lemonex completes a phase I trial in Hypertrophic-scar keloid (In volunteers) in South Korea (SC, Injection) (NCT04707131)